Stock 2395 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shin Nippon Biomedical Laboratories, Ltd.

Equities

2395

JP3379950003

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
1,502 JPY +1.49% Intraday chart for Shin Nippon Biomedical Laboratories, Ltd. +5.55% -11.54%
Feb. 02 Shin Nippon Biomedical Laboratories, Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Jan. 18 Shin Nippon's STS101 Faces Regulatory Hurdle, FDA Requests Refinement for Approval MT

Evolution of the average Target Price on Shin Nippon Biomedical Laboratories, Ltd.

Price target over the last 5 years

History of analyst recommendation changes

7c1cc9f61cb08faa5664bf35ccf26.HE8v9CDAlkoJ91V_LopRmiYfGK0hjpNwAAMPVJfSBIY.Lypqx0qw5nxRgT8oePhlzlxIbsxPuuMgYkptbdCeVsJ6EECAFYmgfl7CGA~7f26fe75cee9b0b5ec1af3c0bc053ab5

Analyst Recommendations on Shin Nippon Biomedical Laboratories, Ltd.

Jefferies Upgrades Shin Nippon Biomedical Laboratories to Buy From Hold, Adjusts Price Target to 2,800 Yen From 2,300 Yen MT
Jefferies Downgrades Shin Nippon Biomedical Laboratories to Hold From Buy, Adjusts Price Target to 2,300 Yen From 3,800 Yen MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,502 JPY
Average target price
3,150 JPY
Spread / Average Target
+109.72%
High Price Target
3,500 JPY
Spread / Highest target
+133.02%
Low Price Target
2,800 JPY
Spread / Lowest Target
+86.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shin Nippon Biomedical Laboratories, Ltd.

Jefferies & Co.

Ratings for Shin Nippon Biomedical Laboratories, Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2395 Stock
  4. Consensus Shin Nippon Biomedical Laboratories, Ltd.